Drew Sansone - Ipsen US LeadershipVice President, Regulatory Affairs, Quality & Safety, North America

Drew Sansone joined Ipsen in May 2016 and brings over twenty-five years of regulatory affairs experience across multiple therapeutic areas at both large multi-national pharmaceutical companies and small to mid-sized biotech companies. He has diverse expertise in all aspects of regulatory affairs and proven successes with multiple international product registrations, first-in-class novel combination therapies, leading submission and approval processes for multiple Global New Chemical Entity submissions, and with maintaining an excellent repertoire with United States and worldwide health authorities. Before joining Ipsen, Drew was most recently at Abbvie where he was responsible for the Hepatitis C franchise. Additionally, he’s held roles at AstraZeneca, Tengion and Vicuron Pharmaceuticals. Drew holds a Masters in Regulatory Affairs and Quality Assurance from Temple University and a Bachelor of Arts in Psychology and Business Administration from Siena College.

Our mission?

To improve patients’ lives

Acting on this mission has propelled us to become a global biopharmaceutical leader with a focus on innovation and specialty care. We help patients through our expertise in oncology, neuroscience, and rare disease.

Find out more about us or see other members of our leadership team.


Products and partnerships

Our products

Our mission is to improve patients’ lives.

See our products


Access our development and commercialization teams. We take bold steps to translate your science and innovations into solutions that make a difference for patients in need.

See more on partnering

Products and partnerships

What’s happening now?

See the latest
©2022 Ipsen Biopharmaceuticals, Inc. MP-US-000472 June 2022